- Home
- JAZZ vs CTRE Comparison
JAZZ vs CTRE Comparison
Compare JAZZ & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- CTRE
- Stock Information
- Founded
- JAZZ 2003
- CTRE 2013
- Country
- JAZZ Ireland
- CTRE United States
- Employees
- JAZZ N/A
- CTRE N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- CTRE Real Estate Investment Trusts
- Sector
- JAZZ Health Care
- CTRE Real Estate
- Exchange
- JAZZ Nasdaq
- CTRE Nasdaq
- Market Cap
- JAZZ 8.2B
- CTRE 7.4B
- IPO Year
- JAZZ 2007
- CTRE N/A
- Fundamental
- Price
- JAZZ $138.54
- CTRE $35.03
- Analyst Decision
- JAZZ Strong Buy
- CTRE Buy
- Analyst Count
- JAZZ 14
- CTRE 5
- Target Price
- JAZZ $180.14
- CTRE $35.00
- AVG Volume (30 Days)
- JAZZ 670.8K
- CTRE 1.8M
- Earning Date
- JAZZ 11-05-2025
- CTRE 11-06-2025
- Dividend Yield
- JAZZ N/A
- CTRE 3.83%
- EPS Growth
- JAZZ N/A
- CTRE 108.23
- EPS
- JAZZ N/A
- CTRE 1.21
- Revenue
- JAZZ $4,086,695,000.00
- CTRE $373,415,000.00
- Revenue This Year
- JAZZ $5.70
- CTRE $23.27
- Revenue Next Year
- JAZZ $6.16
- CTRE $25.44
- P/E Ratio
- JAZZ N/A
- CTRE $28.96
- Revenue Growth
- JAZZ 4.52
- CTRE 50.83
- 52 Week Low
- JAZZ $95.49
- CTRE $24.79
- 52 Week High
- JAZZ $148.06
- CTRE $35.68
- Technical
- Relative Strength Index (RSI)
- JAZZ 62.66
- CTRE 56.17
- Support Level
- JAZZ $134.09
- CTRE $33.96
- Resistance Level
- JAZZ $139.75
- CTRE $35.42
- Average True Range (ATR)
- JAZZ 3.08
- CTRE 0.68
- MACD
- JAZZ -0.21
- CTRE 0.09
- Stochastic Oscillator
- JAZZ 83.51
- CTRE 83.27
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.